Skip to main content
OpenTrials
Completed

NCT Number: NCT07600528

A Exploratory Study of NatureU Sweet Dream on Sleep Outcomes

This was a single-center, open-label, exploratory self-controlled study evaluating NatureU Sweet Dream on sleep outcomes in adults with mild to moderate sleep disturbance. Seventeen participants were enrolled, 2 participants were lost to follow-up, and 15 participants provided valid effectiveness data. Participants completed two independent test-food sessions using wearable sleep monitoring. The comparator session used a commercially available melatonin product, and the test-product session used NatureU Sweet Dream. The main outcomes were deep sleep duration and deep sleep percentage measured by a wearable device and exported through the Huawei Health application. No adverse reactions were reported during the study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–44 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai CTI Medical Laboratory

Shanghai, Shanghai Municipality, China

About this study

The study evaluated the effect of NatureU Sweet Dream, an oral functional food product containing GABA and Lactium, on sleep outcomes. During the screening period, study staff explained the study procedures, product intake method, and wearable monitoring method, and participants signed informed consent before enrollment. Participants were issued a Huawei Band 8 wearable device and the study product. Participants maintained normal diet and routines, avoided alcohol, and used the wearable device for sleep monitoring. In each independent test-food session, participants avoided excessive exercise 2 hours before sleep, took the assigned product with warm water 1 hour before sleep, turned off light sources before sleep, and exported sleep monitoring data the next morning from the Huawei Health application. Study enrollment started on April 15, 2024. Primary completion and last follow-up occurred on April 17, 2024. This exploratory study had no blinding and was intended to generate preliminary within-participant evidence for sleep-related outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Signed informed consent before the study and understood the study content, procedures, and possible adverse reactions.
  • Adult participant with mild to moderate sleep disturbance.
  • Able and willing to use the wearable sleep monitoring device according to study instructions.
  • Able to maintain normal diet and routine habits during the study.
  • Able to avoid alcohol during the study period.
  • Able to avoid excessive exercise 2 hours before sleep during test nights.
  • Able to take the assigned product with warm water 1 hour before sleep during test nights.
  • Willing to complete the full study procedures and provide sleep monitoring data.

Exclusion criteria

  • Known allergy or hypersensitivity to the study product, comparator product, or any related ingredients.
  • Severe sleep disorder or other condition judged by the investigator to make participation inappropriate.
  • Acute or chronic illness that could affect sleep assessment or participant safety.
  • Use of medications, supplements, or procedures that could affect sleep outcomes during the study period.
  • Alcohol intake or other behavior likely to interfere with sleep testing.
  • Inability to use the wearable monitoring device or mobile application as required.
  • Serious protocol deviation or inability to tolerate the test food.
  • Any factor that could seriously affect study results.
  • Any other reason judged by the investigator to require withdrawal or exclusion.

Treatment and study plan

NatureU Sweet Dream

Dietary Supplement

NatureU Sweet Dream is an oral functional food product containing GABA and Lactium. Participants took the product with warm water 1 hour before sleep during the test-product session.

Commercially Available Melatonin Product

Dietary Supplement

The comparator was a commercially available melatonin product taken during the comparator session.

Primary outcomes

  1. Difference in Deep Sleep Duration Between NatureU Sweet Dream and Comparator Product

    Time frame: 24 hours

    Deep sleep duration in minutes was measured using the Huawei Band 8 wearable device and exported from the Huawei Health application after each test-food session. The primary endpoint was the difference in deep sleep duration after NatureU Sweet Dream compared with the commercially available melatonin product.

Secondary outcomes

  1. Difference in Deep Sleep Percentage Between NatureU Sweet Dream and Comparator Product

    Time frame: 24 hours

    Deep sleep percentage was measured using the Huawei Band 8 wearable device and exported from the Huawei Health application after each test-food session. The secondary endpoint was the difference in deep sleep percentage after NatureU Sweet Dream compared with the commercially available melatonin product.

Other outcomes

  1. Safety and Tolerability During Test-Food Sessions

    Time frame: 72 hours

    Safety monitoring included adverse reactions reported during the study. The report stated that no adverse reactions occurred among the 15 participants with valid data.

Sponsors and collaborators

Lead sponsor

OmniSolutions Laboratory Holdings Limited

Industry

Registry information

Official study title

A Single-Center, Open-Label, Exploratory Self-Controlled Study of NatureU Sweet Dream on Deep Sleep Duration and Deep Sleep Percentage in Adults With Sleep Disturbance

Acronym: NUSD

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
May 20, 2026
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.